Toggle Side Panel
AusDoc website
  • News
  • Opinion
  • Jobs
    Login Join
    AusDoc website
    AusDoc website
    • Login
    • Create an account
    • About Us
    • Advertise
    • Contact us
    • Privacy
    • Terms and Conditions
    Close search

    Tag: Tirzepatide

    GLP-1 RAs get boxed warning about the risk of rare but serious eye condition

    July 24, 2026

    Prescribing low doses of GLP-1 RAs a long-term option, Lancet study suggests

    June 2, 2026
    Natalie Raffoul, Heart Foundation head of clinical strategy.

    GLP-1 receptor agonists can improve HFpEF symptoms in patients with obesity, Heart Foundation tells doctors

    May 21, 2026

    Drug company rejects PBS funding offer for tirzepatide as diabetes treatment

    April 28, 2026

    Nearly two thirds of patients who stop GLP-1 RAs continue weight loss efforts: study

    April 8, 2026

    ‘Grave omission’: Most GLP-1 RA studies fail to assess patient diet

    February 11, 2026

    GLP-1 RAs linked to eye complications in JAMA case series

    February 12, 2025

    Join AusDoc to gain full access

    Join for free, in only 30 seconds.

    • 100% free for Australian HCPs
    • Trusted by 60,000+ doctors
    • Instant verification and access
    Join AusDoc

    Already a member? Log in

    • Home
    • Articles
    • Jobs
    • More

    Loading...

    GLP-1 RAs linked to eye complications in JAMA case series

    Report

    There was a problem reporting this post.

    Harassment or bullying behavior
    Contains mature or sensitive content
    Contains misleading or false information
    Contains abusive or derogatory content
    Content that breaches the privacy of other individuals
    Contains spam, fake content or potential malware

    Block Member?

    Please confirm you want to block this member.

    You will no longer be able to:

    • See blocked member's posts
    • Mention this member in posts
    • Message this member
    • Add this member as a connection

    Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

    Report

    You have already reported this .